Skip to main content
Equibles

MORGAN STANLEY

Position in NUVB — Nuvation Bio Inc.

CIK 895421 NEW YORK, NY
Back to NUVB Full portfolio

Position in NUVB

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$8,277,648
+$250,130 QoQ
Shares Held
1,457,333
-22.1% QoQ
Ownership
0.415%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 242 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 70% Shared 0% None 30%

Common Shares in NUVB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. NUVB ranks #149 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in NUVB

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,277,648 1,457,333
2026-03-31 $8,027,518 1,871,217
2025-12-31 $11,434,104 1,276,128
2025-09-30 $4,882,129 1,319,495
2025-06-30 $2,359,113 1,209,803
2025-03-31 $3,467,146 1,969,970
2024-12-31 $2,853,742 1,072,836
2024-09-30 $2,708,771 1,182,871
2024-06-30 $3,032,961 1,038,686
2024-03-31 $4,301,024 1,181,601
2023-12-31 $1,211,838 802,544
2023-09-30 $595,623 444,498
2023-06-30 $1,105,619 614,234
2023-03-31 $744,740 448,641
2022-12-31 $834,992 434,894
2022-09-30 $449,730 200,774
2022-06-30 $590,895 182,376
2022-03-31 $628,839 119,552
2021-12-31 $1,421,776 167,268
2021-09-30 $763,974 76,859
2021-06-30 $488,216 52,440
2021-03-31 $528,247 50,550